BioCentury
ARTICLE | Clinical News

MVA-EBNA/LMP2 vaccine: Phase Ib started

March 31, 2014 7:00 AM UTC

Cancer Research UK said its Drug Development Office ( DDO) began a U.K. Phase Ib trial to evaluate 3 doses of intradermal MVA-EBNA/LMP2 vaccine every 3 weeks followed by another dose 12 weeks later in...